At a glance
- Originator Merck KGaA
- Developer Merck KGaA; Merck Sante
- Class Anxiolytics; Benzonitrile; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obsessive-compulsive disorders
Most Recent Events
- 07 Jun 2001 No-Development-Reported for Obsessive-compulsive disorders in France (Unknown route)
- 07 Jun 2001 No-Development-Reported for Obsessive-compulsive disorders in Germany (Unknown route)
- 08 Dec 1998 New profile